NCT07067099View on ClinicalTrials.gov

Neutralizing Interferon Type 1 in Hidradenitis Suppurativa

PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2026

Study Completion Date

September 30, 2026

Conditions
Hidradenitis Suppurativa (HS)
Interventions
BIOLOGICAL

Plasma with neutralizing autoantibodies to Type I Interferons

Transfusion of one unit of plasma containing high titre anti-IFN-1 autoantibodies

Trial Locations (1)

25000

CHU Besançon, Besançon

All Listed Sponsors
collaborator

Etablissement Français du Sang

OTHER

lead

Centre Hospitalier Universitaire de Besancon

OTHER